A citation-based method for searching scientific literature

R E Ratner, R Dickey, M Fineman, D G Maggs, L Shen, S A Strobel, C Weyer, O G Kolterman. Diabet Med 2004
Times Cited: 164



Matthew Riddle, Juan Frias, Bei Zhang, Holly Maier, Carl Brown, Karen Lutz, Orville Kolterman. Diabetes Care 2007
Times Cited: 66




List of shared articles



Times cited

Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat.
David S Mathiesen, Asger Lund, Tina Vilsbøll, Filip K Knop, Jonatan I Bagger. Front Endocrinol (Lausanne) 2021
0

The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy.
Anna Thorsø Larsen, Nina Sonne, Kim Vietz Andreassen, Morten Asser Karsdal, Kim Henriksen. J Pharmacol Exp Ther 2020
2

The Dual Amylin and Calcitonin Receptor Agonist KBP-088 Induces Weight Loss and Improves Insulin Sensitivity Superior to Chronic Amylin Therapy.
Anna Thorsø Larsen, Nina Sonne, Kim Vietz Andreassen, Kristoffer Gehring, Morten Asser Karsdal, Kim Henriksen. J Pharmacol Exp Ther 2019
6

Pharmacotherapy of type 2 diabetes: An update.
Jagriti Upadhyay, Stergios A Polyzos, Nikolaos Perakakis, Bindiya Thakkar, Stavroula A Paschou, Niki Katsiki, Patricia Underwood, Kyung-Hee Park, Jochen Seufert, Eun Seok Kang,[...]. Metabolism 2018
68

Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition.
John Grizzanti, Rachel Corrigan, Gemma Casadesus. J Alzheimers Dis 2018
5

Neuroendocrine hormone amylin in diabetes.
Xiao-Xi Zhang, Yan-Hong Pan, Yan-Mei Huang, Hai-Lu Zhao. World J Diabetes 2016
20

Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trials.
Kathrin Herrmann, Ming Zhou, Andrew Wang, Tjerk W A de Bruin. Clin Diabetes Endocrinol 2016
6

Role of Amylin in Type 1 and Type 2 Diabetes.
Laura Hieronymus, Stacy Griffin. Diabetes Educ 2015
19

Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy.
Dante J Merlino, Erik S Blomain, Amanda S Aing, Scott A Waldman. J Clin Med 2014
6



Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.
Stuart A Weinzimer, Jennifer L Sherr, Eda Cengiz, Grace Kim, Jessica L Ruiz, Lori Carria, Gayane Voskanyan, Anirban Roy, William V Tamborlane. Diabetes Care 2012
81

Pramlintide: profile of an amylin analog.
Harold E Lebovitz. Expert Rev Endocrinol Metab 2012
0

Primer on pramlintide, an amylin analog.
Andrea N Traina, Michael P Kane. Diabetes Educ 2011
8

Pramlintide and the treatment of diabetes: a review of the data since its introduction.
Lisa M Younk, Maia Mikeladze, Stephen N Davis. Expert Opin Pharmacother 2011
47

Novel strategy for the use of leptin for obesity therapy.
Charmaine S Tam, Virgile Lecoultre, Eric Ravussin. Expert Opin Biol Ther 2011
25

The alpha-cell as target for type 2 diabetes therapy.
Mikkel Christensen, Jonatan I Bagger, Tina Vilsbøll, Filip K Knop. Rev Diabet Stud 2011
28

The role of pramlintide for weight loss.
Kaelen C Dunican, Nicole M Adams, Alicia R Desilets. Ann Pharmacother 2010
19